Horizon Therapeutics Public Ltd Co

Marathon Trading Investment Management LLC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

47,820

Value ($000)

4,918

Weight

3.1%

2020 Q4 - 2023 Q2 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	4,918	3.1%	47,820	6/30/2023
2020 Q4	2/16/2021	966	0.8%	13,200	12/31/2020